Biofil Total Liab from 2010 to 2025

BIOFILCHEM   49.97  1.24  2.54%   
Biofil Chemicals' Total Liabilities is increasing over the years with slightly volatile fluctuation. Overall, Total Liabilities is expected to go to about 348.7 M this year. Total Liabilities is the total amount of all liabilities that Biofil Chemicals Pharmaceuticals has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2009-03-31
Previous Quarter
-182 M
Current Value
236.4 M
Quarterly Volatility
97.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biofil Chemicals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biofil Chemicals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Interest Expense of 354.8 K or Total Revenue of 483.4 M, as well as many indicators such as . Biofil financial statements analysis is a perfect complement when working with Biofil Chemicals Valuation or Volatility modules.
  
This module can also supplement various Biofil Chemicals Technical models . Check out the analysis of Biofil Chemicals Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Biofil Stock

Biofil Chemicals financial ratios help investors to determine whether Biofil Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biofil with respect to the benefits of owning Biofil Chemicals security.